tiprankstipranks
Advertisement
Advertisement

NRSN Stock Latest News

NeuroSense Updates Capital on Demand Program After New F-3 Becomes Effective
Company AnnouncementsNeuroSense Updates Capital on Demand Program After New F-3 Becomes Effective
3d ago
6K
NRSN
NeuroSense Therapeutics Calls August 26 Shareholder Vote on Wide-Range Reverse Share Split
PremiumCompany Announcements
NeuroSense Therapeutics Calls August 26 Shareholder Vote on Wide-Range Reverse Share Split
3d ago
6K
NRSN
NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS
PremiumCompany Announcements
NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS
12d ago
6K
NRSN
NeuroSense to file NDS to Health Canada for PrimeC for treatment of ALS
PremiumThe Fly
NeuroSense to file NDS to Health Canada for PrimeC for treatment of ALS
12d ago
NRSN
NeuroSense Hits Key TDP-43 Endpoint in Phase 2b ALS Trial, Advances Toward Phase 3
PremiumCompany Announcements
NeuroSense Hits Key TDP-43 Endpoint in Phase 2b ALS Trial, Advances Toward Phase 3
1M ago
6K
NRSN
NeuroSense says Phase 2b PARADIGM study of PrimeC in ALS met endpoint
PremiumThe FlyNeuroSense says Phase 2b PARADIGM study of PrimeC in ALS met endpoint
1M ago
NRSN
NeuroSense Posts Positive Phase 2 Biomarker Signals for PrimeC in Alzheimer’s Trial
Premium
Company Announcements
NeuroSense Posts Positive Phase 2 Biomarker Signals for PrimeC in Alzheimer’s Trial
1M ago
6K
NRSN
NeuroSense Secures South Korean Patent for ALS Drug Candidate PrimeC
Premium
Company Announcements
NeuroSense Secures South Korean Patent for ALS Drug Candidate PrimeC
2M ago
6K
NRSN
NeuroSense granted South Korean patent covering PrimeC composition for ALS
PremiumThe Fly
NeuroSense granted South Korean patent covering PrimeC composition for ALS
2M ago
NRSN
NeuroSense Therapeutics Wins Key Japanese Patent for ALS Drug PrimeC
PremiumCompany Announcements
NeuroSense Therapeutics Wins Key Japanese Patent for ALS Drug PrimeC
2M ago
6K
NRSN
NeuroSense granted Japanese patent for PrimeC novel composition in ALS
PremiumThe Fly
NeuroSense granted Japanese patent for PrimeC novel composition in ALS
2M ago
NRSN
NeuroSense Therapeutics Advances Canadian Regulatory Talks on ALS Drug PrimeC
PremiumCompany Announcements
NeuroSense Therapeutics Advances Canadian Regulatory Talks on ALS Drug PrimeC
2M ago
6K
NRSN
NeuroSense Secures Insider-Led $600,000 PIPE at Premium Share Price
PremiumCompany AnnouncementsNeuroSense Secures Insider-Led $600,000 PIPE at Premium Share Price
3M ago
6K
NRSN
NeuroSense announces departure of Chief Medical Officer
Premium
The Fly
NeuroSense announces departure of Chief Medical Officer
3M ago
NRSN
NeuroSense Therapeutics Transitions Chief Medical Officer to Advisory Role Ahead of Key PrimeC Milestones
Premium
Company Announcements
NeuroSense Therapeutics Transitions Chief Medical Officer to Advisory Role Ahead of Key PrimeC Milestones
3M ago
6K
NRSN
NeuroSense Wins Long-Term Brazilian Patent Protection for ALS Drug PrimeC
PremiumCompany Announcements
NeuroSense Wins Long-Term Brazilian Patent Protection for ALS Drug PrimeC
4M ago
6K
NRSN
NeuroSense granted Brazilian patent covering PrimeC composition
PremiumThe Fly
NeuroSense granted Brazilian patent covering PrimeC composition
4M ago
NRSN
NeuroSense Therapeutics Faces Nasdaq Deficiency Notices but Retains Listing Status
PremiumCompany Announcements
NeuroSense Therapeutics Faces Nasdaq Deficiency Notices but Retains Listing Status
4M ago
6K
NRSN
NeuroSense Therapeutics Posts 2025 Results as PrimeC Advances Toward Phase 3 ALS Trial
PremiumCompany Announcements
NeuroSense Therapeutics Posts 2025 Results as PrimeC Advances Toward Phase 3 ALS Trial
4M ago
6K
NRSN
NeuroSense Reschedules Health Canada Meeting as PrimeC Data Package Strengthens
PremiumCompany AnnouncementsNeuroSense Reschedules Health Canada Meeting as PrimeC Data Package Strengthens
4M ago
6K
NRSN
Neurosense Therapeutics Ltd. (NRSN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Neurosense Therapeutics Ltd. (NRSN) Q4 Earnings Cheat Sheet
4M ago
NRSN
NeuroSense’s ALS Drug PrimeC Shows Strong Phase 2b Results in JAMA Neurology
Premium
Company Announcements
NeuroSense’s ALS Drug PrimeC Shows Strong Phase 2b Results in JAMA Neurology
5M ago
6K
NRSN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >